XTNT Stock Analysis: Buy, Sell, or Hold?
XTNT - Xtant Medical Holdings, Inc.
$0.44
0.01 (2.33%)
▲
5d:
-0.02%
30d:
+6.51%
90d:
-19.96%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 11, 2026
7d
Get Alerted When XTNT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: XTNT shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: XTNT shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: XTNT is currently trading at $0.44, which is considered slightly high relative to its 30-day fair value range of $0.41 to $0.44. From a valuation perspective, the stock is trading at a discount (Forward PE: -86.0) compared to its historical average (65.2). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, XTNT is in a strong downtrend. The price is approaching resistance at $0.45. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $1.35 (+214.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, XTNT is in a strong downtrend. The price is approaching resistance at $0.45. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $1.35 (+214.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.41 -
$0.44
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
70.0%
All Signals
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 214.1% below Wall St target ($1.35)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$0.41 -
$0.44
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.41
Resistance Level
$0.45
Current Trend
Strong Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-85.96
Wall Street Target
$1.35
(+214.1%)
Revenue Growth (YoY)
-36.5%
Profit Margin
1.5%
PE vs Historical
-86.0 vs 65.2
CHEAP
Share & Embed Analysis
Last updated: August 03, 2026 2:23 PM ET
Data refreshes hourly during market hours. Next update: 3:23 PM
Data refreshes hourly during market hours. Next update: 3:23 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XTNT showing a specific setup today?
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 52 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 51 HOLD |
